150 related articles for article (PubMed ID: 38392562)
1. Clinical Impact of Comprehensive Molecular Profiling in Adolescents and Young Adults with Sarcoma.
Andrew EC; Lewin J; Desai J; Orme L; Hamilton A; Bae S; Zhu W; Nicolson S; Varghese LN; Mitchell CB; Vissers JHA; Xu H; Grimmond SM; Fox SB; Luen SJ
J Pers Med; 2024 Jan; 14(2):. PubMed ID: 38392562
[TBL] [Abstract][Full Text] [Related]
2. The role of genomic profiling in adolescents and young adults (AYAs) with advanced cancer participating in phase I clinical trials.
McVeigh TP; Sundar R; Diamantis N; Kaye SB; Banerji U; Lopez JS; de Bono J; van der Graaf WTA; George AJ
Eur J Cancer; 2018 May; 95():20-29. PubMed ID: 29614442
[TBL] [Abstract][Full Text] [Related]
3. Profiling of potential driver mutations in sarcomas by targeted next generation sequencing.
Andersson C; Fagman H; Hansson M; Enlund F
Cancer Genet; 2016 Apr; 209(4):154-60. PubMed ID: 26987750
[TBL] [Abstract][Full Text] [Related]
4. Clinical genomic profiling to identify actionable alterations for investigational therapies in patients with diverse sarcomas.
Groisberg R; Hong DS; Holla V; Janku F; Piha-Paul S; Ravi V; Benjamin R; Kumar Patel S; Somaiah N; Conley A; Ali SM; Schrock AB; Ross JS; Stephens PJ; Miller VA; Sen S; Herzog C; Meric-Bernstam F; Subbiah V
Oncotarget; 2017 Jun; 8(24):39254-39267. PubMed ID: 28424409
[TBL] [Abstract][Full Text] [Related]
5. Clinical Impact of Prospective Whole Genome Sequencing in Sarcoma Patients.
Schipper LJ; Monkhorst K; Samsom KG; Bosch LJW; Snaebjornsson P; van Boven H; Roepman P; van der Kolk LE; van Houdt WJ; van der Graaf WTA; Meijer GA; Voest EE
Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053600
[TBL] [Abstract][Full Text] [Related]
6. Clinical Actionability of Comprehensive Genomic Profiling for Management of Rare or Refractory Cancers.
Hirshfield KM; Tolkunov D; Zhong H; Ali SM; Stein MN; Murphy S; Vig H; Vazquez A; Glod J; Moss RA; Belyi V; Chan CS; Chen S; Goodell L; Foran D; Yelensky R; Palma NA; Sun JX; Miller VA; Stephens PJ; Ross JS; Kaufman H; Poplin E; Mehnert J; Tan AR; Bertino JR; Aisner J; DiPaola RS; Rodriguez-Rodriguez L; Ganesan S
Oncologist; 2016 Nov; 21(11):1315-1325. PubMed ID: 27566247
[TBL] [Abstract][Full Text] [Related]
7. Clinical impact of a cancer genomic profiling test using an in-house comprehensive targeted sequencing system.
Hayashi H; Tanishima S; Fujii K; Mori R; Okada C; Yanagita E; Shibata Y; Matsuoka R; Amano T; Yamada T; Yabe I; Kinoshita I; Komatsu Y; Dosaka-Akita H; Nishihara H
Cancer Sci; 2020 Oct; 111(10):3926-3937. PubMed ID: 32772458
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive molecular profiling of sarcomas in adolescent and young adult patients: Results of the EORTC SPECTA-AYA international proof-of-concept study.
Morfouace M; Horak P; Kreutzfeldt S; Stevovic A; de Rojas T; Denisova E; Hutter B; Bautista F; Oliveira J; Defachelles AS; White J; Kasper B; Preusser M; Golfinopoulos V; Pfister S; Van der Graaf W; Wardelmann E; Shenjere P; Fröhling S; McCabe MG
Eur J Cancer; 2023 Jan; 178():216-226. PubMed ID: 36470093
[TBL] [Abstract][Full Text] [Related]
9. Implementing precision oncology for sarcoma patients: the CCC
Berclaz LM; Burkhard-Meier A; Lange P; Di Gioia D; Schmidt M; Knösel T; Klauschen F; von Bergwelt-Baildon M; Heinemann V; Greif PA; Westphalen CB; Heinrich K; Lindner LH
J Cancer Res Clin Oncol; 2023 Nov; 149(15):13973-13983. PubMed ID: 37542550
[TBL] [Abstract][Full Text] [Related]
10. EORTC SPECTA-AYA: A unique molecular profiling platform for adolescents and young adults with cancer in Europe.
de Rojas T; Kasper B; Van der Graaf W; Pfister SM; Bielle F; Ribalta T; Shenjere P; Preusser M; Fröhling S; Golfinopoulos V; Morfouace M; McCabe MG
Int J Cancer; 2020 Aug; 147(4):1180-1184. PubMed ID: 31465545
[TBL] [Abstract][Full Text] [Related]
11. Exploring the feasibility and utility of exome-scale tumour sequencing in a clinical setting.
Lee B; Tran B; Hsu AL; Taylor GR; Fox SB; Fellowes A; Marquis R; Mooi J; Desai J; Doig K; Ekert P; Gaff C; Herath D; Hamilton A; James P; Roberts A; Snyder R; Waring P; McArthur G
Intern Med J; 2018 Jul; 48(7):786-794. PubMed ID: 29607586
[TBL] [Abstract][Full Text] [Related]
12. Circulating tumour DNA in metastatic breast cancer to guide clinical trial enrolment and precision oncology: A cohort study.
Zivanovic Bujak A; Weng CF; Silva MJ; Yeung M; Lo L; Ftouni S; Litchfield C; Ko YA; Kuykhoven K; Van Geelen C; Chandrashekar S; Dawson MA; Loi S; Wong SQ; Dawson SJ
PLoS Med; 2020 Oct; 17(10):e1003363. PubMed ID: 33001984
[TBL] [Abstract][Full Text] [Related]
13. Molecular Profiling of Hard-to-Treat Childhood and Adolescent Cancers.
Khater F; Vairy S; Langlois S; Dumoucel S; Sontag T; St-Onge P; Bittencourt H; Dal Soglio D; Champagne J; Duval M; Leclerc JM; Laverdiere C; Tran TH; Patey N; Ellezam B; Perreault S; Piché N; Samson Y; Teira P; Jabado N; Michon B; Brossard J; Marzouki M; Cellot S; Sinnett D
JAMA Netw Open; 2019 Apr; 2(4):e192906. PubMed ID: 31026031
[TBL] [Abstract][Full Text] [Related]
14. Precision medicine and phosphoproteomics for the identification of novel targeted therapeutic avenues in sarcomas.
Fordham AM; Ekert PG; Fleuren EDG
Biochim Biophys Acta Rev Cancer; 2021 Dec; 1876(2):188613. PubMed ID: 34390800
[TBL] [Abstract][Full Text] [Related]
15. A tailored molecular profiling programme for children with cancer to identify clinically actionable genetic alterations.
George SL; Izquierdo E; Campbell J; Koutroumanidou E; Proszek P; Jamal S; Hughes D; Yuan L; Marshall LV; Carceller F; Chisholm JC; Vaidya S; Mandeville H; Angelini P; Wasti A; Bexelius T; Thway K; Gatz SA; Clarke M; Al-Lazikani B; Barone G; Anderson J; Tweddle DA; Gonzalez D; Walker BA; Barton J; Depani S; Eze J; Ahmed SW; Moreno L; Pearson A; Shipley J; Jones C; Hargrave D; Jacques TS; Hubank M; Chesler L
Eur J Cancer; 2019 Nov; 121():224-235. PubMed ID: 31543384
[TBL] [Abstract][Full Text] [Related]
16. Routine application of next-generation sequencing testing in uro-oncology-Are we ready for the next step of personalised medicine?
Rodler S; Jung A; Greif PA; Rühlmann K; Apfelbeck M; Tamalunas A; Kretschmer A; Schulz GB; Szabados B; Stief C; Heinemann V; Westphalen CB; Casuscelli J
Eur J Cancer; 2021 Mar; 146():1-10. PubMed ID: 33535139
[TBL] [Abstract][Full Text] [Related]
17. Molecular diagnostics enables detection of actionable targets: the Pediatric Targeted Therapy 2.0 registry.
Ecker J; Selt F; Sturm D; Sill M; Korshunov A; Hirsch S; Capper D; Dikow N; Sutter C; Müller C; Sigaud R; Eggert A; Simon T; Niehues T; von Deimling A; Pajtler KW; van Tilburg CM; Jones DTW; Sahm F; Pfister SM; Witt O; Milde T
Eur J Cancer; 2023 Feb; 180():71-84. PubMed ID: 36542877
[TBL] [Abstract][Full Text] [Related]
18. Implementation of paediatric precision oncology into clinical practice: The Individualized Therapies for Children with cancer program 'iTHER'.
Langenberg KPS; Meister MT; Bakhuizen JJ; Boer JM; van Eijkelenburg NKA; Hulleman E; Ilan U; Looze EJ; Dierselhuis MP; van der Lugt J; Breunis W; Schild LG; Ober K; van Hooff SR; Scheijde-Vermeulen MA; Hiemcke-Jiwa LS; Flucke UE; Kranendonk MEG; Wesseling P; Sonneveld E; Punt S; Boltjes A; van Dijk F; Verwiel ETP; Volckmann R; Hehir-Kwa JY; Kester LA; Koudijs MMJ; Waanders E; Holstege FCP; Vormoor HJ; Hoving EW; van Noesel MM; Pieters R; Kool M; Stumpf M; Blattner-Johnson M; Balasubramanian GP; Van Tilburg CM; Jones BC; Jones DTW; Witt O; Pfister SM; Jongmans MCJ; Kuiper RP; de Krijger RR; Wijnen MHW; den Boer ML; Zwaan CM; Kemmeren P; Koster J; Tops BBJ; Goemans BF; Molenaar JJ
Eur J Cancer; 2022 Nov; 175():311-325. PubMed ID: 36182817
[TBL] [Abstract][Full Text] [Related]
19. Transcriptome based individualized therapy of refractory pediatric sarcomas: feasibility, tolerability and efficacy.
Weidenbusch B; Richter GHS; Kesper MS; Guggemoos M; Gall K; Prexler C; Kazantsev I; Sipol A; Lindner L; Nathrath M; Witt O; Specht K; Beitinger F; Knebel C; Hosie S; von Eisenhardt-Rothe R; Weichert W; Luettichau IT; Burdach S
Oncotarget; 2018 Apr; 9(29):20747-20760. PubMed ID: 29755686
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of whole-genome sequencing-based tumor diagnostics in routine pathology practice.
Samsom KG; Schipper LJ; Roepman P; Bosch LJ; Lalezari F; Klompenhouwer EG; de Langen AJ; Buffart TE; Riethorst I; Schoenmaker L; Schout D; van der Noort V; van den Berg JG; de Bruijn E; van der Hoeven JJ; van Snellenberg H; van der Kolk LE; Cuppen E; Voest EE; Meijer GA; Monkhorst K
J Pathol; 2022 Oct; 258(2):179-188. PubMed ID: 35792649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
